Clinical trial
Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving…
NCT00302406 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00302406 |
|---|---|
| Title | Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate |
| Official title | Naturalistic Substitution of Concerta in Adult Subject With ADHD Receiving Immediate Release Methylphenidate |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Intervention type | Drug |
| Interventions | methylphenidate hydrochloride, OROS methylphenidate hydrochloride (CONCERTA) |
| Enrollment | 50 |
| Start date | Jul 1, 2003 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Mar 14, 2006 |
| Last update posted | Jul 12, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: